Soliton, Inc., a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), announced that it

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In